Senator Kennedy On FDA Identification Of Heparin Contaminant
By newsdesk - Posted on March 20th, 2008
March 19, 2008 -- WASHINGTON, DC— Today, Senator Edward M. Kennedy, Chairman of the Health, Education, Labor and Pensions Committee, released the following statement in response to the FDA’s announcement that they have identified the contaminant in the blood thinner heparin, a chemical compound called oversulfated chondroitin sulfate. Senator Kennedy will be sending letters to the FDA and industry later today.
“It is unacceptable that Americans have died and been seriously injured by what appears to be deliberate tampering. Whether this contaminant was introduced intentionally or by accident, the full force of the law must be brought to bear to bring those responsible to justice. To guard against future abuses, every drug manufacturer needs to inform FDA of where it sources its ingredients and what it is doing to ensure that these ingredients are pure and potent.”
Source: Senator Ted Kennedy
Scroll down for related articles:
Related articles
- 2008-03-20: Senator Kennedy On FDA Identification Of Heparin Contaminant
- 2009-11-17: Schumer on Effort To Ban BPA From All Children's Plastic Containers And Canned Food
- 2009-11-17: Merkley on FDA Food Safety Modernization Act
- 2009-11-16: Study Reveals BPA Rates In People Much Higher Than Previously Thought
- 2009-06-24: Senator Murray on Family Smoking Prevention and Tobacco Control Act
- 2009-06-23: Senator Udall Celebrates Tobacco Control Bill
- 2009-06-23: Senator Kennedy on FDA Tobacco Bill
- 2009-06-23: Senator Bingaman on FDA Regulation of Tobacco Products
- 2009-06-05: Senator Mark Udall Urges Support for Bill to Prevent Youth Smoking, Reduce Smoking-Related Health Care Costs
- 2009-06-04: Senator Jack Reed Seeks to Give FDA Authority Over Tobacco
- 2009-05-27: Senator Reed Seeks to Strengthen Sunscreen Labels to Prevent Consumers from Getting Burned
- 2009-05-26: Senators Dodd and Reed Seek to Improve Sunscreen Safety Standards
